Season 3 - Ep.21: Atrial fibrillation in heart failure - Temperature management following cardiac arrest

Jul 31, 2025

Carlos Aguiar, a cardiology expert known for his role on Cardiology This Week, dives into the complexities of atrial fibrillation and heart failure. He discusses how these conditions interact and the implications for patient management. The conversation shifts to the critical issue of temperature management after cardiac arrest, evaluating different cooling methods and their effectiveness. Aguiar also sheds light on the intriguing concept of collider bias in cardiovascular research, emphasizing its importance in deriving accurate findings.

Ask episode

AI Snips

Chapters

Transcript

Episode notes

INSIGHT

Sex Differences in Tricuspid Regurgitation

Tricuspid regurgitation in heart failure shows sex-specific prevalence and mortality impacts.
Women face higher mortality with preserved ejection fraction, men with reduced ejection fraction.

INSIGHT

Obesity's Role in HFpEF

Excess body fat and visceral adiposity are key targets in heart failure with preserved ejection fraction (HFpEF).
Terzepatide improves walk distance and quality of life by reducing weight and waist circumference.

INSIGHT

Invasive Strategy in Elderly NSTEMI

In elderly with non-ST elevation myocardial infarction, invasive management reduces recurrent infarction but not mortality.
Frailty assessment is essential for individualized decision-making.

Get the Snipd Podcast app to discover more snips from this episode

Get the app

This episode covers:

Cardiology this Week: A concise summary of recent studies

Atrial fibrillation in heart failure

Temperature management following cardiac arrest

Statistics Made Easy: Collider bias

Host: Emer Joyce

Guests: Carlos Aguiar, Christian Hassager, Theresa McDonagh

Want to watch that episode? Go to: https://esc365.escardio.org/event/1812

Want to watch that extended interview on temperature management following cardiac arrest? Go to: https://esc365.escardio.org/event/1812?resource=interview

Disclaimer

ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors.

This programme is intended for health care professionals only and is to be used for educational purposes.

The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

The ESC is not liable for any translated content of this video.

The English-language always prevails.

Declarations of interests

Stephan Achenbach, Emer Joyce, Christian Hassager, Nicolle Kraenkel and Theresa McDonagh have declared to have no potential conflicts of interest to report.

Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede.

Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo.

Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.

Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.